Biochemical, molecular chemical and molecular genetic studies were performed on an unknown Gram-positive, catalase-negative, chain-forming coccus isolated from the urine of a patient suffering from cystitis. Comparative 16S rRNA gene sequencing showed that the organism is a member of the ' pyogenic subgroup ' of the genus Streptococcus and has a close affinity with Streptococcus pyogenes and Streptococcus canis. The unknown coccus was, however, readily distinguished from these species and other streptococci by biochemical tests and electrophoretic analysis of whole-cell proteins. Based on phenotypic and phylogenetic evidence, it is proposed that the unknown bacterium be classified as a new species of the genus Streptococcus, Streptococcus urinalis sp. nov. The type strain of Streptococcus urinalis is CCUG 41590 T .
The Gram-positive, catalase-negative cocci embrace many agents which are pathogenic to man and other animals (Facklam & Elliot, 1995 ; Hardie & Whiley, 1991) . During the past decade, there has been much change and improvement in the taxonomy and identification of these organisms. In particular, molecular genetic analysis based on 16S rRNA gene sequencing has facilitated new insights into the phylogenetic interrelationships of the Gram-positive, catalase-negative cocci and provided a powerful means of characterizing new diversity within this important group of bacteria. Indeed, this molecular approach has been primarily responsible for the very considerable increase in the number of newly described Gram-positive, catalasenegative organisms in recent years. Many of these newly delineated organisms represent new members of established genera, such as Enterococcus and Streptococcus, which have long been associated with disease, whereas in other cases, they constitute species of previously unknown genera [e.g. Alloiococcus (Aguirre & Collins, 1992) , Dolosigranulum (Aguirre et al., 1993) , Globicatella (Collins et al., 1992) , Facklamia , Helcococcus (Collins et al., 1993) and Ignavigranum ]. In the past few years, 16S rRNA gene sequencing has been used, in concert with phenotypic tests, to investigate numerous atypical or unknown strains of Gram-positive, catalase-negative cocci from human sources aimed at facilitating their recognition and identification. In the course of this ongoing study, the characteristics of an unknown coccus isolated from human urine are reported. Phylogenetic analysis shows that the organism represents a new subline within the ' pyogenic subgroup ' of the genus Streptococcus, for which the species name Streptococcus urinalis is proposed.
Strain 2285-97 T was sent from the Michigan State Health Department (USA) to the Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA) for identification. The organism was isolated from the urine of a 55-year-old female patient with cystitis and chronic abdominal pain. The strain has been deposited in the Culture Collection of the University of Go$ teborg (CCUG), under accession number CCUG 41590 T . The unidentified organism was cultured on Columbia agar (Difco) supplemented with 5 % sheep blood at 37 mC, in air plus 5 % CO # . The strain was biochemically characterized using the API Rapid ID32 STREP and API ZYM systems according to the manufacturer's instructions (API bioMe! rieux). Conventional biochemical and physiological tests were also performed (Facklam & Elliot, 1995) . Preparation of cellular protein extracts for PAGE analysis, densitometric analysis, normalization of the protein profiles and numerical analysis were performed as described by Pot et al. (1994) Streptococcus urinalis sp. nov.
The DNA GjC content (mol %) was determined by thermal denaturation as described by Garvie (1978) . The 16S rRNA gene(s) of the isolate was amplified by PCR and directly sequenced using a Taq DyeDeoxy terminator cycle sequencing kit (Applied Biosystems) and an automatic DNA sequencer (model 373A ; Applied Biosystems). The closest known relatives of the new isolate were determined by performing database searches. These sequences and those of known related strains were retrieved from the GenBank or Ribosomal Database Project databases and aligned with the newly determined sequence using the program  (Devereux et al., 1984) . The resulting multiple sequence alignment was corrected manually and a distance matrix was calculated using the programs  and  (using the Kimura-two correction parameter) (Felsenstein, 1989) . A phylogenetic tree was constructed according to the neighbour-joining method with the program  (Felsenstein, 1989) . The stability of the groupings was estimated by bootstrap analysis (500 replications) using the programs , ,  and  (Felsenstein, 1989) .
The unidentified isolate consisted of Gram-positive, ovoid shaped cells which formed short chains. The organism grew on normal media routinely used for streptococci and was non-haemolytic and non-motile. Employing conventional tests used by CDC (Facklam & Elliot, 1995) , the organism did not form gas on MRS broth, was bile\aesculin-positive, grew in broth containing 6n5 % NaCl, and at 45 mC but not at 10 mC. The isolate produced acid in heart infusion base medium from glucose, lactose, maltose, ribose, sucrose and trehalose, but not from arabinose, glycerol, inulin, melibiose, sorbitol or sorbose. It produced leucine aminopeptidase and pyroglutamic acid arylamidase, hydrolysed aesculin but not urea, hippurate or starch, formed acid and clot in litmus milk, and was vancomycin-sensitive and bacitracin-resistant. Using commercially available API systems, the isolate produced acid from maltose, ribose, sucrose and trehalose, but failed to produce acid from -arabinose, -arabitol, cyclodextrin, glycogen, lactose, mannitol, melibiose, melezitose, methyl β--glucopyranoside, Nacetylglucosamine, pullulan, sorbitol, raffinose or tagatose. It gave positive reactions for acid phosphatase, alkaline phosphatase, arginine dihydrolase, α-glucosidase, β-glucosidase, pyroglutamic acid arylamidase and leucine arylamidase, but was negative for alanine-phenylalanine-proline arylamidase, chymotrypsin, esterase C4, ester lipase C8, α-fucosidase, α-galactosidase, β-galactosidase, β-galacturonidase, β-glucuronidase, glycyl-tryptophan arylamidase, lipase C14, α-mannosidase, β-mannosidase, trypsin and valine arylamidase. The organism was Voges-Proskauerpositive. The morphological and biochemical characteristics of the unknown isolate were consistent with its assignment to Streptococcus, although it did not seem to correspond to any of the currently defined species of this genus. To further investigate the phenotypic similarities of the unknown bacterium, PAGE of whole-cell proteins was performed. The results of a numerical analysis of the protein patterns of the unknown coccus and representative strains of currently recognized streptococcal species are shown in Fig. 1 pyogenes\S. canis is also very much greater than that which may be expected between different strains of the same species. For example, in the case of streptococcal species, levels of sequence divergence of 0n5 % or less, have been reported for partial and\or near complete 16S rRNAs of strains of the same species [Streptococcus pluranimalium (Devriese et al., 1999) ; Streptococcus parasanguinis (Fernandez Garayzabal et al., 1998) ; S. parauberis (Domenech et al., 1996) ; Streptococcus hyovaginalis and Streptococcus thoraltensis (Devriese et al., 1997) ; Streptococcus infantis and Streptococcus peroris (Kawamura et al., 1998) ]. This is also the case for all other Gram-positive, catalasenegative, coccus-shaped taxa for which intra-specific sequence divergence values are available (e.g. Gemella spp., Facklamia spp.). In addition to the above genetic findings, the unknown isolate is phenotypically quite distinct from S. pyogenes and S. canis. The unknown coccus can be readily distinguished from S. pyogenes and S. canis in that it is non-haemolytic and by the absence of group CH antigens, especially group A and G. Both S. pyogenes and S. canis display strong β-haemolytic activity, and are positive for Lancefield group A and G antigens, respectively (Ruoff, 1991) . In addition, the unknown coccus differs from S. pyogenes and S. canis in numerous other physiological and biochemical traits (see Table 1 ). Strong support for the separateness of the unidentified coccus also comes from PAGE whole-cell protein profiling (Fig. 1) . It is now firmly established that this molecular chemical approach is extremely reliable for comparing closely related strains and shows excellent correlation with DNA-DNA hybridizations (Vandamme et al., 1996) . The PAGE protein profiling results shown in Fig. 1 unequivocally demonstrate that the unknown isolate is a separate species from S. pyogenes and S. canis. Therefore, based on the distinct phenotypic characteristics of the unknown coccus, and the use of molecular chemical and molecular genetic evidence in concert, it is firmly believed that the unidentified coccus from human urine represents a hitherto unknown species, for which the name Streptococcus urinalis sp. nov. is proposed. It is important to note that currently only a single strain of Streptococcus urinalis is known. Although species descriptions based on a single strain are not desirable, the recovery of this organism from a human clinical specimen, together with its distinct taxonomic characteristics, justifies its recognition as a new species. In addition, it is considered that the formal description of Streptococcus urinalis will greatly facilitate the isolation of further strains of this species.
Description of Streptococcus urinalis sp. nov.
Streptococcus urinalis (u.ri.nahlis. M.L. adj. urinalis pertaining to urine).
Cells are Gram-positive, ovoid in shape, occurring singly, in pairs or in short chains. Cells are nonpigmented, non-haemolytic and non-motile. Spores are not produced. Facultatively anaerobic, oxidasenegative and catalase-negative. Growth does not occur at 10 mC. Growth occurs in broth containing 6n5% NaCl. Bile\aesculin-positive. Negative with streptococcal group A, B, C, D, E, F and G antisera. Gas is not produced in MRS broth. Positive for leucine aminopeptidase and pyrrolidonyl arylamidase. Pyruvate is not utilized. Using conventional heart infusion base medium, acid is produced from glucose, lactose, ribose, sucrose, maltose and trehalose. Acid is not produced from arabinose, glycerol, inulin, melibiose, sorbitol or sorbose. Using API systems, acid is produced from maltose, ribose, sucrose and trehalose, but not from -arabinose, -arabitol, cyclodextrin, glycogen, lactose, mannitol, melibiose, melezitose, methyl β--glucopyranoside, N-acetylglucosamine, pullulan, sorbitol, raffinose or tagatose. It is positive for acid phosphatase, alkaline phosphatase, arginine dihydrolase, α-glucosidase, β-glucosidase, pyroglutamic acid arylamidase and leucine arylamidase, but negative for alanine-phenylalanine-proline arylamidase, chymotrypsin, esterase C4, ester lipase C8, α-fucosidase, α-galactosidase, β-galactosidase, β-galacturonidase, β-glucuronidase, glycyl-tryptophan arylamidase, lipase C14, α-mannosidase, β-mannosidase, trypsin and valine arylamidase. Urea and starch are not hydrolysed. Acetoin is produced. Extracellular polysaccharide is not produced. Acid and clot are formed in litmus milk. Vancomycin-sensitive and bacitracin-resistant. Negative reaction with Enterococcus GenProbe test. The GjC content of DNA is 39 mol %. The type strain is CCUG 41590 T .
